Legend Biotech
LEGN
LEGN
140 hedge funds and large institutions have $1.85B invested in Legend Biotech in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 68 increasing their positions, 31 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.27% more ownership
Funds ownership: 16.42% → 16.69% (+0.27%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
21% less capital invested
Capital invested by funds: $2.33B → $1.85B (-$481M)
Holders
140
Holding in Top 10
5
Calls
$19.3M
Puts
$12.9M
Top Buyers
| 1 | +$58.6M | |
| 2 | +$37.1M | |
| 3 | +$23.3M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$16.2M |
| 5 |
FFM
FengHe Fund Management
Singapore
|
+$15.9M |
Top Sellers
| 1 | -$177M | |
| 2 | -$21.6M | |
| 3 | -$17.4M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$15.7M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$14.3M |